Genmab A/S (GMAB) Reports Q3 Net DARZALEX Sales of $2.5B

Go back to Genmab A/S (GMAB) Reports Q3 Net DARZALEX Sales of $2.5B
(NASDAQ: GMAB) Delayed: 31.14 +1.31 (4.39%)
Previous Close $29.83    52 Week High
Open $31.44    52 Week Low
Day High $31.79    P/E N/A 
Day Low $30.92    EPS
Volume 2,517,061